Clinical Trials Browser

Phase 2 × Amyloidosis × Clear all

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT04991103 2025-12-31

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

Phase 2 Recruiting

40 enrolled

Plasma cell

Amyloidosis, Multiple Myeloma, Neoplasm, Residual

NCT07285044 2025-12-22

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Phase 2 Recruiting

27 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidMyeloidPlasma cellThoracic

Amyloidosis, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Lung Neoplasms, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Lymphoma, Mantle-Cell

NCT02924272 2025-03-12

Ixazomib Rollover Study

Phase 2 Completed

32 enrolled 13 charts

LymphoidPlasma cell

Amyloidosis, Lymphoma, Multiple Myeloma

NCT05066607 2024-03-06

IsAMYP

Phase 2 Unknown

46 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT03959358 2023-07-24

A Study to Desensitize Allergic Reactions to Treatments for Blood Disorders

Phase 2 Completed

10 enrolled

Plasma cell

Amyloidosis, Multiple Myeloma

NCT00224393 2023-05-30

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

Phase 2 Completed

60 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT02207556 2021-07-09

DUAL

Phase 2 Completed

32 enrolled 15 charts

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01083316 2020-09-25

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Phase 2 Completed

35 enrolled 9 charts

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis

NCT01222260 2020-03-30

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

Phase 2 Completed

40 enrolled 10 charts

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01447914 2019-08-28

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Phase 2 Completed

16 enrolled 11 charts

Classical hematologyOther hematologic neoplasmPlasma cell

Amyloidosis, Anemia, Bone Diseases, Metabolic, Fractures, Spontaneous, Hypercalcemia, Multiple Myeloma, Osteolysis, Paraproteinemias, Hematologic Neoplasms, Renal Insufficiency

NCT02632786 2019-04-05

PRONTO

Phase 2 Completed

129 enrolled 18 charts

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Paraproteinemias

NCT02791373 2018-04-03

ViGeM

Phase 2 Completed

136 enrolled

Plasma cell

Amyloidosis, Multiple Myeloma

NCT01677286 2017-08-01

Safety and Effect of Doxycycline in Patients With Amyloidosis

Phase 2 Completed

25 enrolled 13 charts

Plasma cell

AA amyloidosis, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Amyloidosis, Familial

NCT01548573 2017-06-14

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

Phase 2 Terminated

19 enrolled 7 charts

Plasma cell

Amyloidosis, Endocrine System Diseases, Multiple Myeloma, Paraproteinemias, Polyneuropathies

NCT01194791 2017-04-25

LENDEXAL

Phase 2 Completed

30 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT00017680 2008-06-09

Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

Phase 2 Completed

25 enrolled

Other hematologic neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Arthritis, Connective Tissue Diseases, Hematologic Neoplasms, Genetic Diseases, Inborn, Rare Diseases, Neoplasms, Plasma Cell

Clinical Trials

ALANIS

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Ixazomib Rollover Study

IsAMYP

A Study to Desensitize Allergic Reactions to Treatments for Blood Disorders

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

DUAL

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

PRONTO

ViGeM

Safety and Effect of Doxycycline in Patients With Amyloidosis

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

LENDEXAL

Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis